http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002039773-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-02019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d42adb51ff3011f947b5b8e99e6414c |
| publicationDate | 2002-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002039773-A1 |
| titleOfInvention | 47885, a novel human ubiquitin-activating enzyme and uses therefor |
| abstract | The invention provides isolated nucleic acids molecules, designated 47885 nucleic acid molecules, which encode novel ubiquitin-activating enzyme family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 47885 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 47885 gene has been introduced or disrupted. The invention still further provides isolated 47885 proteins, fusion proteins, antigenic peptides and anti-47885 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| priorityDate | 2000-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 791.